Hart A, Panaccione R, Steinwurz F, Danese S, et al. Efficacy and Safety of Guselkumab Subcutaneous Induction and Maintenance in Participants with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 GRAVITI Study. Gastroenterology 2025 Mar 18:S0016-5085(25)00522.
PMID: 40113101